B. I. Carr Et Al. , "CRP is a superior and prognostically significant inflammation biomarker for hepatocellular cancer patients treated by liver transplantation.," Clinical practice (London, England) , vol.18, no.2, pp.1626-1632, 2021
Carr, B. I. Et Al. 2021. CRP is a superior and prognostically significant inflammation biomarker for hepatocellular cancer patients treated by liver transplantation.. Clinical practice (London, England) , vol.18, no.2 , 1626-1632.
Carr, B. I., Ince, V., Bag, H. G., Usta, S., Ersan, V., Isik, B., ... Yilmaz, S.(2021). CRP is a superior and prognostically significant inflammation biomarker for hepatocellular cancer patients treated by liver transplantation.. Clinical practice (London, England) , vol.18, no.2, 1626-1632.
Carr, Brian Et Al. "CRP is a superior and prognostically significant inflammation biomarker for hepatocellular cancer patients treated by liver transplantation.," Clinical practice (London, England) , vol.18, no.2, 1626-1632, 2021
Carr, Brian I. Et Al. "CRP is a superior and prognostically significant inflammation biomarker for hepatocellular cancer patients treated by liver transplantation.." Clinical practice (London, England) , vol.18, no.2, pp.1626-1632, 2021
Carr, B. I. Et Al. (2021) . "CRP is a superior and prognostically significant inflammation biomarker for hepatocellular cancer patients treated by liver transplantation.." Clinical practice (London, England) , vol.18, no.2, pp.1626-1632.
@article{article, author={Brian I Carr Et Al. }, title={CRP is a superior and prognostically significant inflammation biomarker for hepatocellular cancer patients treated by liver transplantation.}, journal={Clinical practice (London, England)}, year=2021, pages={1626-1632} }